These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 15934123

  • 1. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A.
    Arthritis Rheum; 2005 Jun 15; 53(3):452-9. PubMed ID: 15934123
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C.
    Lupus; 2007 Jun 15; 16(10):810-6. PubMed ID: 17895304
    [Abstract] [Full Text] [Related]

  • 7. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.
    Fijnheer R, Roest M, Haas FJ, De Groot PG, Derksen RH.
    J Rheumatol; 1998 Sep 15; 25(9):1737-42. PubMed ID: 9733454
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E, Magder LS, Petri M.
    J Rheumatol; 2002 Dec 15; 29(12):2531-6. PubMed ID: 12465147
    [Abstract] [Full Text] [Related]

  • 9. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE, Gonzalez-Pares EN, Rivera C.
    P R Health Sci J; 2006 Dec 15; 25(4):307-13. PubMed ID: 17550096
    [Abstract] [Full Text] [Related]

  • 10. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H.
    Scand J Rheumatol; 2004 Dec 15; 33(4):246-52. PubMed ID: 15370721
    [Abstract] [Full Text] [Related]

  • 11. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N.
    Thromb Haemost; 1999 Mar 15; 81(3):436-41. PubMed ID: 10102474
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 15; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 13. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun 15; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 14. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Jun 15; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 15. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM, Vayá A, Todolí J, Calvo J, Villa P, Estellés A, España F, Santaolaria M, Corella D, Aznar J.
    Thromb Haemost; 2006 Apr 15; 95(4):618-24. PubMed ID: 16601831
    [Abstract] [Full Text] [Related]

  • 16. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170
    [Abstract] [Full Text] [Related]

  • 17. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL, Rauch J, Grodzicky T, Raynauld JP, Uthman I, Nava A, Guimond M, Raymond Y.
    Arthritis Rheum; 1999 Jul 15; 42(7):1347-53. PubMed ID: 10403261
    [Abstract] [Full Text] [Related]

  • 18. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 15; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 19. The 677C --> T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus.
    Afeltra A, Amoroso A, Mitterhofer AP, Vadacca M, Galluzzo S, Francia A, Del Porto F, Gandolfo GM.
    Seizure; 2002 Jun 15; 11(4):250-4. PubMed ID: 12027572
    [Abstract] [Full Text] [Related]

  • 20. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr 15; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.